Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial
From MaRDI portal
Publication:4975358
DOI10.1080/01621459.2013.842488zbMath1367.62296OpenAlexW2000341825WikidataQ37649570 ScholiaQ37649570MaRDI QIDQ4975358
L. Tian, Layla Parast, Tianxi Cai
Publication date: 4 August 2017
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3960087
Applications of statistics to biology and medical sciences; meta analysis (62P10) Reliability and life testing (62N05)
Related Items (6)
Estimating the average treatment effect on survival based on observational data and using partly conditional modeling ⋮ Evaluating multiple surrogate markers with censored data ⋮ Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes ⋮ Rejoinder to “Causal mediation of semicompeting risks” ⋮ Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards ⋮ Landmark estimation of survival and treatment effects in observational studies
Cites Work
- Unnamed Item
- Dimension reduced kernel estimation for distribution function with incomplete data
- Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data
- Inconsistency of the misspecified proportional hazards model
- Towards a general asymptotic theory for Cox model with staggered entry
- Regression analysis under link violation
- Inference on endogenously censored regression models using conditional moment inequalities
- On semi-competing risks data
- Improving the efficiency of the log-rank test using auxiliary covariates
- Semiparametric dimension reduction estimation for mean response with missing data
- Calibrating parametric subject-specific risk estimation
- The loss in efficiency from misspecifying covariates in proportional hazards regression models
- On Inference in Parametric Survival Data Models
- A kernel method for incorporating information on disease progression in the analysis of survival
- Nonparametric Survival Estimation Using Prognostic Longitudinal Covariates
- Estimating medical costs with censored data
- Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information
- Evaluating Prediction Rules fort-Year Survivors With Censored Regression Models
- Incorporating short‐term outcome information to predict long‐term survival with discrete markers
- Dynamic Prediction by Landmarking in Event History Analysis
- Model evaluation based on the sampling distribution of estimated absolute prediction error
- Some comments on efficiency gains from auxiliary information for right-censored data
This page was built for publication: Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial
